David Scadden - Jul 1, 2024 Form 4 Insider Report for Carisma Therapeutics Inc. (CARM)

Role
Director
Signature
/s/ Eric Siegel, as Attorney-in-Fact for David Scadden
Stock symbol
CARM
Transactions as of
Jul 1, 2024
Transactions value $
$0
Form type
4
Date filed
7/1/2024, 07:17 PM
Previous filing
Jul 1, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CARM Stock Option (Right to Buy) Award $0 +38.7K $0.00 38.7K Jul 1, 2024 Common Stock 38.7K $1.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest over three years in equal monthly installments following July 1, 2024, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date.